Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

15 million Connected Disposable Medical Sensors to Ship by 2023

ABI Research
Posted on: 07 Sep 17

PR Newswire

OYSTER BAY, N.Y., Sept. 7, 2017

OYSTER BAY, N.Y., Sept. 7, 2017 /PRNewswire/ -- The adoption of an emerging generation of disposable, connected sensors will be driven by the ongoing development of remote patient monitoring applications, according to the latest healthcare report from ABI Research. Combined with use in hospitals and clinics, shipments of single-use sensors capable of transmitting patient data wirelessly, will exceed 3.5 million sensors annually by 2022, growing at a CAGR of 30% from 2016 shipments.

"Disposables are already a feature of healthcare provision around the globe and medical sensors will have to fit into that world. Efforts already underway promise considerable progress over the next few years," says Jonathan Collins, Research Director at ABI Research. "Their potential to extend and simplify the benefits of remote patient monitoring will help drive the adoption of both," he says.

Disposable sensors, without embedded wireless transmitters are already commonplace in remote patient continuous glucose monitoring applications from Dexcom, Medtronic and others, but their potential reaches far beyond. Disposable connected sensors can support applications including medication tracking, temperature, heart rate and pulse oximetry as well as activity/movement/post-surgery orthopedics monitoring that address a far larger user-base.

A host of companies ranging from established players including Philips Healthcare and Medtronic to well-backed ventures like Qualcomm Life and smaller start-ups like GenTag and Proteus Digital Health are all investing in developing disposable sensors, but are taking varied approaches regarding sensor format and supporting technologies. In addition, a range of wireless protocols are under consideration for adoption in disposable smart health sensors including Bluetooth, NFC and Proprietary offerings.

"What these and many other companies share is an understanding that healthcare workflows and reimbursement payments are already steeped in the broad use of disposable devices. Between now and 2022 will be a key time for these vendors and others to address technical and ecosystem complexity around disposable sensor connectivity. It will also be the primary time for vendors to gain a foothold in the emerging market," says Collins.

These findings are from ABI Research's Disposable Medical Sensors report. This report is part of the company's Smart Health research service, which includes research, data, and analyst insights. 

About ABI Research

ABI Research stands at the forefront of technology market intelligence, providing business leaders with comprehensive research and consulting services to help them implement informed, transformative technology decisions. Founded more than 25 years ago, the company's global team of senior and long-tenured analysts delivers deep market data forecasts, analyses, and teardown services. ABI Research is an industry pioneer, proactively uncovering ground-breaking business cycles and publishing research 18 to 36 months in advance of other organizations. For more information, visit www.abiresearch.com.

Contact Info:




Americas

EMEA/APAC

Deborah Petrara

Denise Duffy

Tel: +1.516.624.2558

Tel: +44.203.326.0142

pr@abiresearch.com

duffy@abiresearch.com

 

View original content with multimedia:http://www.prnewswire.com/news-releases/15-million-connected-disposable-medical-sensors-to-ship-by-2023-300515434.html

SOURCE ABI Research

PR Newswire
www.prnewswire.com

Last updated on: 07/09/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.